Lion Point Capital »

Lantheus Holdings Inc Common Stock Usd 0.01 shares owned by Lion Point Capital

Quarter-by-quarter ownership of Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) shares owned by Lion Point Capital from 13F filings

Historical chart of Lion Point Capital investment in Lantheus Holdings Inc Common Stock Usd 0.01

Tip: Access up to 7 years of quarterly data

All positions including Lantheus Holdings Inc Common Stock Usd 0.01 held by Lion Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lantheus Holdings Inc Common Stock Usd 0.01 by Lion Point Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $366k 5.5k 66.55

More positions owned by Lion Point Capital

Milestone Pharmaceuticals (MIST)
Praxis Precision Medicines I Com New (PRAX)
Moonlake Immunotherapeutics Class A Ord (MLTX)
Fennec Pharmaceuticals (FENC)
Jasper Therapeutics Com New (JSPR)
Benitec Biopharma Com New (BNTC)
Royalty Pharma Shs Class A (RPRX)
Geron Corporation (GERN)
Syndax Pharmaceuticals (SNDX)
Ardelyx (ARDX)
Cue Biopharma (CUE)
Disc Medicine (IRON)
Sarepta Therapeutics (SRPT)
Biohaven (BHVN)
Humacyte (HUMA)

View all positions for Lion Point Capital

Top funds holding Lantheus Holdings Inc Common Stock Usd 0.01

BlackRock
Vanguard Group
Henderson Group
Farallon Capital Management
FMR
State Street Corporation
Geode Capital Management
Reinhart Mahoney Capital Management
Dimensional Fund Advisors
Swedbank AB
Norges Bank Investment Management
Carmignac Gestion
Point72 Asset Management
Deerfield Management Company
Northern Trust

View all funds holding Lantheus Holdings Inc Common Stock Usd 0.01